In accordance with the previous results, overexpression of transgelin-2 (TG2) in OTI T cells did not enhance T cell adhesion to ovalbumin (OVA)-pulsed B16F10 target cells in vitro and showed only a mild effect on B16F10 tumor regression in vivo (Fig. 1a, b). The gene discussed is TAGLN2; the disease is neoplasm.